Laurel Habel to Treatment Outcome
This is a "connection" page, showing publications Laurel Habel has written about Treatment Outcome.
Connection Strength
0.301
-
Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol. 2014 Jul 10; 32(20):2151-8.
Score: 0.090
-
Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.
Score: 0.066
-
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.
Score: 0.066
-
Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative. Oncologist. 2020 08; 25(8):712-721.
Score: 0.034
-
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
Score: 0.018
-
Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause. 2007 May-Jun; 14(3 Pt 1):391-6.
Score: 0.014
-
Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(1):47-57.
Score: 0.013